Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  American Journal of Respiratory and Critical Care Medicine

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1164/AJRCCM.153.1.8542165PMID 8542165
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nedocromil sodium versus albuterol in the management of allergic asthma.

  1994cited by this paper
• Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.

  1994cited by this paper
• A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.

  1994cited by this paper
• Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.

  1993cited by this paper
• Regular inhaled salbutamol and airway responsiveness to allergen.

  1993cited by this paper
• Airway responsiveness : standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults

  1993cited by this paper
• Asthma control during and after cessation of regular beta 2-agonist treatment.

  1993cited by this paper
• Is the association between inhaled beta-agonist use and life-threatening asthma because of confounding by severity?

  1993cited by this paper
• The Use of β-Agonists and the Risk of Death and near Death from Asthma

  1992cited by this paper
• Tolerance to the Nonbronchodilator Effects of Inhaled β2-Agonists in Asthma

  1992cited by this paper
• A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.

  1992cited by this paper
• Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma.

  1992cited by this paper
• Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group.

  1992cited by this paper
• Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.

  1992cited by this paper
• The use of beta-agonists and the risk of death and near death from asthma.

  1992cited by this paper
• Fatal and near-fatal asthma.

  1991cited by this paper
• Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.

  1991cited by this paper
• Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma.

  1991cited by this paper
• Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on bronchial hyperresponsiveness and diurnal variation in peak flow.

  1991cited by this paper
• FATAL AND NEAR-FATAL ASTHMA

  1991cited by this paper
• Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol.

  1990cited by this paper
• Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics.

  1990cited by this paper
• Regular inhaled beta-agonist treatment in bronchial asthma.

  1990cited by this paper
• Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline.

  1988cited by this paper
• Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma.

  1987cited by this paper
• Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline.

  1985cited by this paper
• Regulation of beta-adrenergic receptors by steroid hormones.

  1984cited by this paper
• Regulation of β-Adrenergic Receptors by Steroid Hormones

  1984cited by this paper
• Standardized lung function testing.

  1984cited by this paper

• Inhaled anticholinergics and short-acting beta(2)-agonists versus short-acting beta2-agonists alone for children with acute asthma in hospital.

  2014cites this paper
• Rebound effect of drugs: fatal risk of conventional treatment and pharmacological basis of homeopathic treatment

  2012cites this paper
• Bronchodilators, fatal asthma, rebound effect and similitude

  2007cites this paper
• Evidence of the principle of similitude in modern fatal iatrogenic events

  2006cites this paper
• Concluding remarks

  2006cites this paper
• Meta-Analysis: Respiratory Tolerance to Regular 2-Agonist Use in Patients with Asthma

  2004cites this paper
• Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment.

  2003cites this paper
• β2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells

  2002cites this paper
• Dry-Powder Inhalers

  2001cites this paper
• Asthma, asthma medication and autonomic nervous system dysfunction.

  2001cites this paper
• Budesonide for chronic asthma in children and adults.

  2001cites this paper
• A placebo-controlled clinical trial of regular monotherapy with short-acting and long-acting beta(2)-agonists in allergic asthmatic patients.

  2001cites this paper
• Genetics of asthma and atopy

  2001cites this paper
• Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.

  2000cites this paper
• Inhaled short acting beta2-agonist use in asthma: regular vs as needed treatment.

  2000cites this paper
• Is Chronic Use of β2-Agonists Detrimental in the Treatment of Asthma?

  2000cites this paper
• Budesonide versus placebo for chronic asthma in children and adults

  1999cites this paper
• Similitude in modern pharmacology

  1999cites this paper
• Detection of muscarinic receptors in the human lung using PET.

  1999cites this paper
• Efficacy and safety of inhaled corticosteroids. New developments.

  1998cites this paper
• Universal Declaration on the Human Genome and Human Rights, Unesco

  1997cites this paper
• Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis

  1997cites this paper
• Effects of cessation of terbutaline treatment on airway obstruction and responsiveness in patients with chronic obstructive pulmonary disease.

  1996cites this paper
• Reduced upper airway nitric oxide in cystic fibrosis.

  1996cites this paper
• b 2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells

  year unknowncites this paper